Andrographolide: a diterpenoid from Cymbopogon schoenanthus identified as a new hit compound against Trypanosoma cruzi using machine learning and experimental approaches
J Chem Inf Model, v. 64, n. 7, p. 2565-2576, dez. 2023
Article
em En
| SES-SP, SESSP-IBPROD, SES-SP
| ID: bud-5215
Biblioteca responsável:
BR78.1
ABSTRACT
American Trypanosomiasis, also known as Chagas disease, is caused by the protozoan Trypanosoma cruzi and exhibits limited options for treatment. Natural products offer various structurally complex metabolites with biological activities, including those with anti-T. cruzi potential. The discovery and development of prototypes based on natural products frequently display multiple phases that could be facilitated by machine learning techniques to provide a fast and efficient method for selecting new hit candidates. Using Random Forest and k-Nearest Neighbors, two models were constructed to predict the biological activity of natural products from plants against intracellular amastigotes of T. cruzi. The diterpenoid andrographolide was identified from a virtual screening as a promising hit compound. Hereafter, it was isolated from Cymbopogon schoenanthus and chemically characterized by spectral data analysis. Andrographolide was evaluated against trypomastigote and amastigote forms of T. cruzi, showing IC50 values of 29.4 and 2.9 μM, respectively, while the standard drug benznidazole displayed IC50 values of 17.7 and 5.0 μM, respectively. Additionally, the isolated compound exhibited a reduced cytotoxicity (CC50 = 92.8 μM) against mammalian cells and afforded a selectivity index (SI) of 32, similar to that of benznidazole (SI = 39). From the in silico analyses, we can conclude that andrographolide fulfills many requirements implemented by DNDi to be a hit compound. Therefore, this work successfully obtained machine learning models capable of predicting the activity of compounds against intracellular forms of T. cruzi.
Texto completo:
1
Coleção SES:
Producao_cientifica
Base de dados:
SES-SP
/
SESSP-IBPROD
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article